Clinical Trial Update: A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese Participants [Phase 1]

View source ↗

Summary

This ClinicalTrials.gov update reports the completion of a Phase 1 study evaluating LY3549492 in healthy Japanese participants and in Japanese participants with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• LY3549492 (LY3549492)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Healthy, Type 2 Diabetes Mellitus (T2D) | Phase 1 | Status: COMPLETED